1. Abrams EM, Greenhawt M (2020) Risk communication during COVID-19. J Allergy Clin Immunol Pract 8(6):1791
2. CDC (2019a). Symptoms of coronavirus. Centers for disease control and prevention. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html#seek-medical-attention. Accesses 27 Oct 2020.
3. CDC (2019b). Interim clinical guidance for management of patients with confirmed coronavirus disease. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html. Accessed 27 Oct 2020.
4. CDC (2019c). People with certain medical conditions. Centers for disease control and prevention. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html. Accessed 27 Oct 2020.
5. Cummings C, Rosenthal S, Kong WY (2020) Secondary risk theory: validation of a novel model of protection motivation. Risk Anal 41(1):204–220. https://doi.org/10.1111/risa.13573